Bluefield Innovations FAQ Pages

Q: What is the collaboration between Johns Hopkins University and Deerfield Management?

A: Johns Hopkins University is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to accelerate the translation of research in Johns Hopkins University faculty laboratories into clinical therapeutics. Bluefield Innpvations is a Deerfield company that will support Johns Hopkins University's innovative translational research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development.
Bluefield Innovations will fund projects with the aim of establishing novel therapeutics to cure life-altering diseases.
Through Bluefield Innovations, Deerfield has committed up to $65 million in initial funding to support promising Johns Hopkins University translational research. Deerfield will provide operational support and may make additional capital investments into spin-off companies that emerge from Johns Hopkins University projects and show commercial potential.

Q: Who is eligible to apply?

A: Principal Investigators whose full-time employer is Johns Hopkins University or who have a faculty appointment at Johns Hopkins University and are subject to Johns Hopkins University’s policies regarding the conduct of research and ownership of intellectual property.

Q: How can I apply?

A: To submit an application, please visit the Request for Proposal (RFP) page on the Bluefield Innovations website.

Q: How many calls for proposal are there in a year?

A: There are two calls for proposals each year.

Q: Does Bluefield have a therapeutic area of interest?

A: No – We welcome applications from all therapeutic areas.

Additional FAQs are available once eligible applicants have registered through the submission portal.